Baxalta, the biopharmaceutical spinoff of Baxter, entered into a $1.7 B deal with Precision BioSceinces for 6 CAR-T (Chimeric Antigen Receptor T-cell) projects, and Saronic Biotechnology announced positive data in preclinical studies of its autologous dendritic cell vaccine for hepatocellular carcinoma. Continue reading
Tag Archives: gene editing
![](https://blogs.shu.edu/cancer/files/2014/07/cancerBiology180x110.jpg)
Gene-edited donor T-cells save baby with incurable leukemia
An experimental therapy made of genetically-modified donor T-cells cured a baby with incurable leukemia: Continue reading